(19)
(11) EP 4 798 620 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24880812.3

(22) Date of filing: 25.10.2024
(51) International Patent Classification (IPC): 
C07K 16/18(2006.01)
A61P 25/28(2006.01)
A61K 39/00(2006.01)
C07K 14/47(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/18; C07K 2317/622; C07K 2317/76; A61P 25/28; A61K 2039/505; A61K 2039/54; A61K 2039/545; C07K 2317/34; C07K 2317/21; C07K 2317/33
(86) International application number:
PCT/AU2024/051130
(87) International publication number:
WO 2025/085971 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 27.10.2023 AU 2023903449

(71) Applicant: The University of Queensland
St Lucia, Queensland 4072 (AU)

(72) Inventors:
  • GOETZ, Juergen
    St Lucia, Queensland 4072 (AU)
  • GONZALEZ, Esteban Cruz
    St Lucia, Queensland 4072 (AU)
  • NISBET, Rebecca
    St Lucia, Queensland 4072 (AU)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) ANTI-TAU THERAPEUTIC ANTIBODY FOR AD AND TAUOPATHIES